Explore the vast range of titles available.

Background Newcastle disease virus (NDV) is a causative agent of Newcastle disease (ND), a major infectious poultry disease associated with significant economic losses. Vaccination is usually effective at preventing the disease. However, in Ethiopia, ND is commonly detected in both unvaccinated and vaccinated chickens. In this study, we aimed to evaluate the pathogenicity of NDV isolated from both vaccinated and unvaccinated chickens, as well as to compare the antigenicity of the isolates with vaccine strains and genotyping by using the F -gene sequence. Methods The partial F gene sequences of all isolates and the mean death times (MDTs) of representative isolates were used to determine genotype and pathogenicity of the isolates. Antigenicities were assayed with the hemagglutinin inhibition (HI) and virus neutralization (VN) tests using antiserum against the vaccine Hitchner B1 (HB1), which is the most commonly used NDV vaccine in Ethiopia. Thermostability was evaluated by incubating infected allantoic fluid at 56 °C. Results Out of 231 samples tested, 10.8% (25/231) were positive for virus isolation. The F gene cleavage sites of all 25 isolates had 112 RRQKRF 117 , a characteristic of virulent NDVs. The MDTs of representative isolates were less than 60 h, indicating highly virulent (velogenic) pathotypes. The HI test revealed significant differences between our isolates and the HB1 vaccine strain, but the VN test showed no antigenic difference. Phylogenetic analysis based on the partial F gene sequences showed that all the isolates belonged to sub-genotype VII.1.1 of genotype VII, which is closely related to NDV strains from the Middle East and Eritrea. Thermostability test showed two of the 25 isolates were thermostable. Discussion Although the HI test indicates antigenic differences between the velogenic Ethiopian isolates and the HB1 vaccine, the VN test showed that the vaccine could protect infections with these isolates. Phylogenetic analysis showed that all studied isolates belong to sub-genotype VII.1.1 of genotype VII, diverging from previously reported genotype XXI in Ethiopia. Conclusions In Ethiopia, NDV genotype VII 1.1 is widely distributed. Since these viruses showed the same antigenicity as the HB1 vaccine in VN test, the occurrence of ND in vaccinated chickens may be due to vaccine failure caused by inadequate management or immunosuppression due to other infectious diseases.

Newcastle disease (ND), caused by Newcastle disease virus (NDV), is a contagious disease that affects a variety of domestic and wild avian species. Though ND is vaccine-preventable, it is a persistent threat to poultry industry across the globe. The disease represents a leading cause of morbidity and mortality in chickens. To better understand the epidemiology of NDV among commercial and backyard chickens of Odisha, where chicken farming is being prioritized to assist with poverty alleviation, a cross-sectional study was conducted in two distinct seasons during 2018. Choanal swabs ( n = 1361) from live birds (commercial layers, broilers, and backyard chicken) and tracheal tissues from dead birds ( n = 10) were collected and tested by real-time reverse transcription polymerase chain reaction (RT-PCR) for the presence of matrix (M) and fusion (F) genes of NDV. Risk factors at the flock and individual bird levels (health status, ND vaccination status, geographical zone, management system, and housing) were assessed using multivariable logistic regression analyses. Of the 1371 samples tested, 160 were positive for M gene amplification indicating an overall apparent prevalence of 11.7% (95% CI 10.1–13.5%). Circulation of virulent NDV strains was also evident with apparent prevalence of 8.1% (13/160; 95% CI: 4.8–13.4%). In addition, commercial birds had significantly higher odds (75%) of being infected with NDV as compared to backyard poultry ( p = 0.01). This study helps fill a knowledge gap in the prevalence and distribution of NDV in apparently healthy birds in eastern India, and provides a framework for future longitudinal research of NDV risk and mitigation in targeted geographies—a step forward for effective control of ND in Odisha.

Poultry production is one of the fastest-growing agricultural sub-sectors in Nigeria. However, it faces numerous challenges, mainly from frequent Newcastle disease (ND) outbreaks even in vaccinated flocks, causing huge economic losses. The recurring outbreaks raise concerns about the efficacy of ND vaccine and the need to understand the immunomodulatory mechanism of the ND virus (NDV). This study investigated a recent outbreak of NDV that resulted in 95% mortality in a vaccinated broiler parent stock in Nigeria by utilizing immunoinformatic tools to elucidate the possible immune evasion features of the disease-causing NDV. Genetic analysis of the complete fusion gene showed that the NDV isolate belong to sub-genotype XIV.2, a virulent strain prevalent in Nigeria. Predicted immunogenic peptides from the sub-genotype XIV.2 proteins revealed notable amino acid variations (R114Q, V118I, A220V) in both Major Histocompatibility Complex class I and II epitopes compared to common NDV vaccine and other prominent field strains. Modelling and structural validation of the BF2*2101 chicken allele showed 99% residues within the allowed regions in Ramachandran plot and − 6.61 Z-score, confirming its reliability. Immune simulation indicated that LaSota-Komorov prime-boost vaccine-simulation could not confer protection against sub-genotype XIV.2 virus simulated-challenge, despite eliciting humoral immune response. These results provide a valuable insight for developing ND vaccines that could effectively counter the immune cell interference of sub-genotype XIV.2, although further experimental validation is needed to characterize key biological interactions. A multifaceted approach encompassing improved biosecurity and the development of an effective sub-genotype XIV.2-matched vaccine is crucial to mitigate the persistent threat of ND in Nigeria.

Strains of Newcastle disease virus (NDV) can be separated into genotypes based on genome differences even though they are antigenically considered to be of a single serotype. It is widely recognized that an efficacious Newcastle disease (ND) vaccine made with any NDV does induce protection against morbidity and mortality from a virulent NDV challenge. However, those ND vaccines do not protect vaccinates from infection and viral shed from such a challenge. Vaccines prepared from ND viruses corresponding to five different genotypes were compared to determine if the phylogenetic distance between vaccine and challenge strain influences the protection induced and the amount of challenge virus shed. Six groups of 4-week-old specific pathogen-free Leghorn chickens were given oil-adjuvanted vaccines prepared from one of five different inactivated ND viruses including strains B1, Ulster, CA02, Pigeon84, Alaska196, or an allantoic fluid control. Three weeks post-vaccination, serum was analyzed for antibody content using a hemagglutination inhibition assay against each of the vaccine antigens and a commercial NDV ELISA. After challenge with virulent CA02, the birds were examined daily for morbidity and mortality and were monitored at selected intervals for virus shedding. All vaccines except for the control induced greater than 90% protection to clinical disease and mortality. The vaccine homologous with the challenge virus reduced oral shedding significantly more than the heterologous vaccines. NDV vaccines formulated to be phylogenetically closer to potential outbreak viruses may provide better ND control by reducing virus transmission from infected birds.

Newcastle disease virus (NDV) is an avian pathogen with an unsegmented negative-strand RNA genome that belongs to the Paramyxoviridae family. While primarily pathogenic in birds, NDV presents no threat to human health, rendering it a safe candidate for various biomedical applications. Extensive research has highlighted the potential of NDV as a vector for vaccine development and gene therapy, owing to its transcriptional modularity, low recombination rate, and lack of a DNA phase during replication. Furthermore, NDV exhibits oncolytic capabilities, efficiently eliciting antitumor immune responses, thereby positioning it as a promising therapeutic agent for cancer treatment. This article comprehensively reviews the biological characteristics of NDV, elucidates the molecular mechanisms underlying its oncolytic properties, and discusses its applications in the fields of vaccine vector development and tumor therapy.

Between 2019 and 2023, 163 cases of subgenotype VII.1.1 Newcastle disease virus infection were registered in backyard poultry in the Russian Federation within the framework of epizootiological monitoring. Subgenotype VII.1.1 Newcastle disease virus was reported in a total of 18 different subjects of the Russian Federation. Most of the Newcastle disease outbreaks caused by the viruses of this subgenotype occurred in the autumn and winter period (60%). Further tests allowed for the determination of complete F and HN gene nucleotide sequences for 40 isolates. The results were used to perform the Bayesian analysis of F gene sequences with BEAST v.1.10.4 software. The obtained nucleotide substitution accumulation rates were practically non-dependent on the selected nucleotide substitution model and varied appreciably depending on the applied molecular clock model (0.0018 and 0.002 site-1year-1). The conducted study established that the formation of the ‘Russian’ NDV isolates of subgenotype VII.1.1 followed several stages. In the early 2000s, ancestral viruses belonging to subgenotype VII-d were detected in the Middle East and Eastern Europe. From these, through intermediate forms identified in Iraq around 2007–2008, a group designated as subgenotype VII-L emerged. This group gave rise to two sister clades: the Iranian subgenotype VII-L and the cluster of isolates from Russia and Poland, whose immediate common ancestor likely existed around 2015–2016, probably in Asia.

Newcastle disease virus (NDV) is a significant member of the Paramyxoviridae family, known for causing epidemics and substantial economic losses in the poultry industry worldwide. The NDV RNA genome primarily encodes six structural proteins (N, P, M, F, HN, and L) and two non-structural proteins (V and W). Among these, the polymerase-associated proteins (N, P, and L) and the viral RNA (vRNA) genome form the ribonucleoprotein complex, which plays a crucial role in the synthesis and transcription of NDV vRNA. In the last two decades, numerous studies have demonstrated that the polymerase-associated proteins are linked to the virulence, pathotype, and thermostability of NDV. Additionally, the interactions between these polymerase-associated proteins and host proteins are closely related to the NDV’s replication and pathogenicity. Despite significant progress in understanding the unique and shared functions of NDV polymerase-associated proteins, research on these viral proteins’ structure and function is less comprehensive than other NDV proteins, and the available information is often scattered. Therefore, this article systematically summarises and reviews the research progress made in understanding the structural features, virulence, pathotype, and thermostability correlation of NDV polymerase-associated proteins, as well as the critical roles of interactions between polymerase-associated proteins and host proteins in NDV replication and pathogenicity. This review aims to enhance our understanding of the complex functions of polymerase-associated proteins in NDV replication and pathogenesis and to contribute to the development of more effective vaccines and antiviral drugs against NDV challenges.

Newcastle disease virus (NDV) can infect over 250 bird species with variable pathogenicity; it can also infect humans in rare cases. The present study investigated an outbreak in feral pigeons in São Paulo city, Brazil, in 2019. Affected birds displayed neurological signs, and hemorrhages were observed in different tissues. Histopathology changes with infiltration of mononuclear inflammatory cells were also found in the brain, kidney, proventriculus, heart, and spleen. NDV staining was detected by immunohistochemistry. Twenty-seven out of thirty-four tested samples (swabs and tissues) were positive for Newcastle disease virus by RT-qPCR test, targeting the M gene. One isolate, obtained from a pool of positive swab samples, was characterized by the intracerebral pathogenicity index (ICPI) and the hemagglutination inhibition (HI) tests. This isolate had an ICPI of 0.99, confirming a virulent NDV strain. The monoclonal antibody 617/161, which recognizes a distinct epitope in pigeon NDV strains, inhibited the isolate with an HI titer of 512. A complete genome of NDV was obtained using next-generation sequencing. Phylogenetic analysis based on the complete CDS F gene grouped the detected isolate with other viruses from subgenotype VI.2.1.2, class II, including one previously reported in Southern Brazil in 2014. This study reports a comprehensive characterization of the subgenotype VI.2.1.2, which seems to have been circulating in Brazilian urban areas since 2014. Due to the zoonotic risk of NDV, virus surveillance in feral pigeons should also be systematically performed in urban areas.

Newcastle disease (ND) virus (NDV) infection ranks among the most important poultry diseases globally. In Nigeria, ND remains a persistent menace to poultry production, marked by recurrent outbreaks. However, there is limited understanding of the evolutionary changes and transmission dynamics of the virus in the region. A molecular epidemiological study was conducted to elucidate the evolutionary and transmission patterns of NDV in Nigeria. Phylogenetic analysis of seven NDV isolates from cases recorded between 2023 and 2024 in four Northeastern states exhibited genetic diversity and formed distinct clusters that correspond to the prevailing subgenotype XIV.2. The maximum clade credibility (MCC) tree suggests sustained local circulation of the dominant NDV lineage, likely preceded by an international introduction from Southeast Asia. The fusion genes of the Nigerian genotype XIV and another important genotype XVII are mainly under negative selection, but codons 516 (XIV) and 114 (XVII) consistently show positive selection. The Nextstrain analysis reveals ongoing local evolution and genetic diversity of NDV in West Africa, and Central Nigeria acting as a key transmission hub, with evidence of reintroductions from neighboring countries. These findings have implications for NDV control and prevention strategies in Nigeria, highlighting the need for enhanced NDV surveillance, transboundary transmission control, and development of a vaccine tailored to the circulating NDV genotypes. The study also contributes to the understanding of regional spread pattern of NDV and informs evidence-based policies for mitigating the impact of the disease on poultry production.

Newcastle disease (ND) is caused by virulent strains of avian paramyxovirus type 1, also known as Newcastle disease virus (NDV). Despite vaccination, the frequency of reported outbreaks in Ethiopia has increased. From January to June 2022, an active outbreak investigation was conducted in six commercial chicken farms across areas of central Ethiopia to identify the circulating NDV strains. Thirty pooled tissue specimens were collected from chickens suspected of being infected with NDV. A questionnaire survey of farm owners and veterinarians was also carried out to collect information on the farms and the outbreak status. NDV was isolated using specific-pathogen-free (SPF)-embryonated chicken eggs and detected using haemagglutination and the reverse transcriptase–polymerase chain reaction (RT–PCR). The genotype and virulence of field NDV isolates were determined using phylogenetic analysis of fusion (F) protein gene sequences and the mean death time (MDT) test in SPF-embryonated chicken eggs. The questionnaire results revealed that ND caused morbidity (23.1%), mortality (16.3%), case fatality (70.8%), and significant economic losses. Eleven of thirty tissue specimens tested positive for NDV using haemagglutination and RT–PCR. The MDT testing and sequence analysis revealed the presence of virulent NDV classified as genotype VII of class II velogenic pathotype and distinct from locally used vaccine strains (genotype II). The amino acid sequences of the current virulent NDV fusion protein cleavage site motif revealed 112RRQKR↓F117, unlike the locally used avirulent vaccine strains (112GRQGR↓L117). The epidemiological data, MDT results, cleavage site sequence, and phylogenetic analysis all indicated that the present NDV isolates were virulent. The four NDV sequences were deposited in GenBank with accession numbers F gene (PP726912-15) and M gene (PP726916-19). The genetic difference between avirulent vaccine strains and circulating virulent NDV could explain the low level of protection provided by locally used vaccines. Further studies are needed to better understand the circulating NDV genotypes in different production systems.